Clinical Trial Details

Trial ID: L0705
Source ID: NCT04308980
Associated Drug: SPP-1
Title: Development and Evaluation of the Effectiveness of Complex Therapy of Steatohepatitis of Various Aetiologies Based on Metabolomic Analysis With the Use of Innovative Medical Nutrition Products
Acronym: 52920190055
Status: Recruiting
Study Results: No Results Available
Results: --
Conditions: NAFLD;NASH - Nonalcoholic Steatohepatitis
Interventions: Dietary Supplement: Specialized product for medical nutrition (SPP-1);Behavioral: individualized diet
Outcome Measures: Weight change;Change of satiety level;Change of hunger level;Presence of adverse events;Change of proportion of fat in body composition;Change of proportion of water in body composition;Change of lean body weight;Change in blood docosahexaenoic acid concentration;Change in blood hydroxyeycosatetraenoic acid concentrationChange of serum glucose concentration;Change of serum insulin concentration;Change of serum triglycerides concentration;Change of serum high-density lipoprotein concentration;Change of serum low-density lipoprotein concentration;Change of serum cholesterol concentration;Change of serum gamma-glutamine transpeptidase (GGT) activity level;Change of serum alanine amino-transferase (AST) activity level;Change of serum alanine amino-transferase (ALT) activity
Sponsor/Collaborators: Russian Academy of Medical Sciences
Gender: All
Age: 18 Years70 Years
Phases: Phase 2/Phase 3
Enrollment: 45
Study Type: Interventional
Study Designs: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Start Date: 12/03/2020
Completion Date: --
Results First Posted: --
Last Update Posted: 16 February 2021
Locations: Russian Federation
URL: https://clinicaltrials.gov/show/NCT04308980